Malaria Clinical Trial
Official title:
Responding to Efficacy Decay Analysis of Artemisinin Based Combination Therapy (ACTs) in Rural Tanzania: Intervening on Provider Compliance and Patient Adherence to Correct Malaria Treatment
INDEPTH Network Effectiveness and Safety Studies in Africa (INESS) have demonstrated a
substantial efficacy decay of Artemisinin based combination therapy (ACT) in Tanzania in
2012 (from efficacy of 98% to effectiveness of 18%). Hence system readiness for control and
elimination strategies is severely compromised. Sub-optimal health workers' performance in
treating malaria cases was a major contributor to the decay, effecting both treatment and
patient adherence. If these quantified system failures remain unchecked it will pose major
barrier in achieving malaria control and elimination goals. There is growing evidence that
mobile phone text message reminders can improve health workers' compliance and patients'
adherence to malaria treatment guidelines. Tanzania has recently harnessed all public sector
health worker phones into Short Message System (SMS) platform. The investigators intend to
exploit this opportunity in a randomized trial of messages to substantially reduce the decay
documented by the INESS platform.
The null hypothesis: Sending automated text message reminders to health workers on malaria
diagnosis and treatment recommendations, will not have any effects in the quality of malaria
case management.
The baseline assessment of systems effectiveness performed by this team, have done a
comprehensive quantitative documentation of efficacy decay for ACTs in real world settings;
showing how community and provider's contribute to efficacy decay. The proposed text
messages reminder intervention builds up from the recent findings of the Kenyan study which
demonstrated an improvement in malaria case management by 24%. This level of improvement in
malaria case management, if coupled with other systems interventions to improve timely
access to ACT providers, should at least double systems effectiveness. This being the case,
health systems in developing countries will be able to address these significant challenges
hindering taking the diseases eradication agenda forward. Inappropriate care and untimely
access to treatment has been identified as one of important elements for ACTs efficacy decay
that in turn continues to pose a serious challenge to achieving malaria eradication.
Goal: The study aim to evaluate using cluster randomized control trial whether mobile phone
text messages reminders can improve the quality of malaria case management.
Specific objectives:
1. To develop an automated text messaging system to send reminders to mobile phones of
health workers based on Tanzanian malaria treatment guidelines;
2. To evaluate the impact of the intervention on providers' compliance to the National
Guidelines for Malaria Diagnosis and Treatment (NGMDT);
3. To evaluate the impact of the intervention on patients adherence to malaria treatment
with ACT
4. To evaluate the impact of the intervention on reducing baseline efficacy decay levels.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
Completed |
NCT02605720 -
Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns
|
Phase 3 |